Sign in
WithdrawnNo phase

Equitable Smoking Relapse Prevention

Key facts

Who runs it
Bryan W. Heckman
Where
Nashville, United StatesSee the site
Trial code
Status
Withdrawn
Started
2 Oct 2023
Ended
30 Nov 2023
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Quitbuddy
  • Control
  • SDoH Augmentation
  • SDoH Control
Record updated
8 May 2024
Why it stopped
Change in Principal Investigator Affilation/Role

Who can take part

Age
21 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • At least 21 years of age
  • Smoking at least 10 cigarettes per day for the past year
  • Literate in English/Spanish
  • Willing to make a NRT-aided quit attempt within the next week

Who cannot take part

  • Current use (past 30 days) of alternative tobacco products (e.g., electronic cigarettes, smokeless tobacco) or smoking cessation medications (self-report)
  • Recent (past 3 months) cardiovascular trauma: myocardial infarction, stroke (self-report)
  • Pregnancy (according to urine pregnancy test)
  • Breastfeeding or planning to become pregnant (self-report)

Where in United States

  • Meharry Medical CollegeNashville, United States

About the trial

What the trial wants to find out

The goal of this clinical trial is to test a GPS (Global Positioning System)-enabled smartphone app (QuitBuddy) in current smokers. The main questions it aims to answer are:

Read full original descriptionShow less

* Is Quitbuddy a good treatment for quitting smoking and "staying quit"? * Will a second treatment that connects people to help for their social and financial needs improve Quitbuddy?

Participants will:

* get nicotine lozenges in the mail * check in with the study team to report on their quitting progress after 1 day, 1 week, 1 month, 2 months, 3 months, and 6 months

Researchers will compare Quitbuddy to an app made by the National Cancer Institute to see if Quitbuddy is better for helping people stay quit.

The 2 groups in the trial

  • QuitbuddyTreatment being tested

    Participants will be assigned to use a smartphone app (QuitBuddy) that will automatically guide NRT treatment delivery through the integration of ecological momentary assessments (EMA) and GPS into personalized relapse prevention algorithms.

    Treatment: Quitbuddy, SDoH Augmentation, and SDoH Control

  • ControlExisting treatment, for comparison

    Control is intended to approximate the real-world experience where Participants will use The National Cancer Institute's smartphone app (QuitGuide) and will self-manage NRT treatment delivery based on written instructions.

    Treatment: Control, SDoH Augmentation, and SDoH Control

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Accelerating Health Equity Via Just-In-Time Adaptive Interventions (JITAIs): Scalable and High Impact mHealth Precision Smoking Relapse Prevention.
Record updated
8 May 2024